Lynx1 Capital Management LP - 31 Dec 2024 SCHEDULE 13G Report for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (ALLO)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: ALLO
Shares outstanding: 209,129,288 shares
Disclosed Ownership: 10,874,723 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 09:02:11 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	5.2%	10,874,723	0	10,874,723	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	5.2%	10,874,723	0	10,874,723	/s/ Weston Nichols	Weston Nichols, Individually